PubRank
Search
About
Jianghong Deng
Author PubWeight™ 27.27
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.
Proc Natl Acad Sci U S A
2007
4.05
2
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.
Mol Cell Proteomics
2008
1.88
3
Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.
Clin Cancer Res
2012
1.74
4
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
Mol Cell Proteomics
2008
1.44
5
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.
J Proteome Res
2008
1.42
6
Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.
PLoS One
2010
1.35
7
Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.
Cancer Prev Res (Phila)
2012
1.14
8
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.
Lab Invest
2010
1.09
9
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker.
Clin Colorectal Cancer
2009
1.00
10
Activated VEGF receptor shed into the vitreous in eyes with wet AMD: a new class of biomarkers in the vitreous with potential for predicting the treatment timing and monitoring response.
Arch Ophthalmol
2009
0.98
11
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
J Proteome Res
2011
0.94
12
Effect of the knockdown of podocin mRNA on nephrin and alpha-actinin in mouse podocyte.
Exp Biol Med (Maywood)
2004
0.94
13
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins.
J Proteome Res
2012
0.91
14
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
J Proteome Res
2009
0.90
15
Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.
Clin Cancer Res
2013
0.88
16
Key molecular events in puromycin aminonucleoside nephrosis rats.
Pathol Int
2004
0.87
17
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.
Clin Cancer Res
2013
0.86
18
A pilot characterization of human lung NSCLC by protein pathway activation mapping.
J Thorac Oncol
2012
0.85
19
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Proteomics
2015
0.82
20
Stratification of clear cell renal cell carcinoma by signaling pathway analysis.
Expert Rev Proteomics
2014
0.81
21
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment.
Clin Colorectal Cancer
2012
0.78
22
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations.
Clin Exp Metastasis
2012
0.78
23
The role of Haemophilus influenzae type b in fatal community-acquired pneumonia in Chinese children.
Pediatr Infect Dis J
2008
0.77
24
Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.
J Proteome Res
2011
0.76
25
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker.
Clin Colorectal Cancer
2009
0.76